Press Releases
OAKVILLE, ON, May 9, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q1 2022 financial results on Thursday, May 12, 2022 after market close. The Company will also host a conference call on Friday, May 13, 2022 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: | May 13, 2022 |
TIME: | 8:30 a.m. ET |
DIAL-IN NUMBER: | (647) 484-0477 or (888) 458-4121 |
CONFERENCE ID: | 6137413 |
REPLAY DIAL-IN: | (888) 203-1112 (playback 6137413#) |
Expires May 20, 2022 | |
WEBCAST: | https://produceredition.webcasts.com/starthere.jsp?ei=1548662&tp_key=a2eab0e46f |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
